Literature DB >> 12633910

Predictors of follow-up health status in the Drug Abuse Treatment Outcome Study (DATOS).

Peter D Friedmann1, Stephenie C Lemon, Bradley J Anderson, Michael D Stein.   

Abstract

This study examined the predictors of self-reported health status at follow-up in the Drug Abuse Treatment Outcomes Study (DATOS), a longitudinal study of drug abuse treatment programs and patients in 1991-1993. Baseline and follow-up interviews of 2966 patients in 75 programs were performed. The follow-up assessment was targeted to occur 12 months after treatment terminated; long-term methadone patients in treatment for the entire 12-month period were interviewed 24 months after intake. A composite measure, developed through principal component analysis, assessed health status. A multivariate hierarchical linear regression model adjusted for identified independent baseline predictors of health status at follow-up. Poor physical health status (including the composite measure, comorbid conditions and pain) and greater severity of psychiatric symptoms at baseline were the strongest predictors of poor health status at follow-up. Other predictors of worse health status included older age, public insurance coverage and unemployment. We conclude that baseline health status and psychiatric symptoms predict the subsequent health status of patients in substance abuse treatment patients as in other clinical populations. Future research should examine whether early identification and treatment of physical and mental health problems among patients in addiction treatment programs might remediate their adverse effects on long-term health status outcomes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12633910     DOI: 10.1016/s0376-8716(02)00323-x

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  10 in total

1.  Pain and continued opioid use in individuals receiving buprenorphine-naloxone for opioid detoxification: secondary analyses from the Clinical Trials Network.

Authors:  Jennifer Sharpe Potter; Amit Chakrabarti; Catherine P Domier; Maureen P Hillhouse; Roger D Weiss; Walter Ling
Journal:  J Subst Abuse Treat       Date:  2010-06

2.  Effect of primary medical care on addiction and medical severity in substance abuse treatment programs.

Authors:  Peter D Friedmann; Zhiwei Zhang; James Hendrickson; Michael D Stein; Dean R Gerstein
Journal:  J Gen Intern Med       Date:  2003-01       Impact factor: 5.128

3.  Predictors of active injection drug use in a cohort of patients infected with hepatitis C virus.

Authors:  Carrie Reed; Caleb Bliss; Sherri O Stuver; Timothy Heeren; Sheila Tumilty; C Robert Horsburgh; Jeffrey H Samet; Deborah J Cotton
Journal:  Am J Public Health       Date:  2012-11-15       Impact factor: 9.308

4.  Nine-year psychiatric trajectories and substance use outcomes: an application of the group-based modeling approach.

Authors:  Felicia W Chi; Constance M Weisner
Journal:  Eval Rev       Date:  2008-02

5.  Ethnicity and gender comparisons of health consequences in adults with alcohol dependence.

Authors:  Karen G Chartier; Michie N Hesselbrock; Victor M Hesselbrock
Journal:  Subst Use Misuse       Date:  2013-01-10       Impact factor: 2.164

6.  Co-occurring Mental Disorders in Substance Abuse Treatment: the Current Health Care Situation in Germany.

Authors:  Hanna Dauber; Barbara Braun; Tim Pfeiffer-Gerschel; Ludwig Kraus; Oliver Pogarell
Journal:  Int J Ment Health Addict       Date:  2017-07-11       Impact factor: 3.836

7.  The Association of Drug-Use Characteristics and Active Coping Styles With Positive Affect in Patients With Heroin-Use Disorder and Methamphetamine-Use Disorder During the COVID-19 Pandemic.

Authors:  Yingying Wang; Jinsong Zuo; Long Wang; Qianjin Wang; Xin Wang; Qian Yang; Hanjing Emily Wu; Colin B Goodman; Dongmei Wang; Tieqiao Liu; Xiangyang Zhang
Journal:  Front Public Health       Date:  2021-12-03

8.  Impact of co-occurring psychiatric disorders on retention in a methadone maintenance program: an 18-month follow-up study.

Authors:  Mònica Astals; Laura Díaz; Antònia Domingo-Salvany; Rocío Martín-Santos; Antoni Bulbena; Marta Torrens
Journal:  Int J Environ Res Public Health       Date:  2009-11-12       Impact factor: 3.390

9.  Recovery post treatment: plans, barriers and motivators.

Authors:  Paul Duffy; Helen Baldwin
Journal:  Subst Abuse Treat Prev Policy       Date:  2013-01-30

10.  The long-term outcome of patients with heroin use disorder/dual disorder (chronic psychosis) after admission to enhanced methadone maintenance.

Authors:  Angelo G I Maremmani; Alessandro Pallucchini; Luca Rovai; Silvia Bacciardi; Vincenza Spera; Marco Maiello; Giulio Perugi; Icro Maremmani
Journal:  Ann Gen Psychiatry       Date:  2018-04-18       Impact factor: 3.455

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.